Tissue contact assessment with combined mapping and ablation catheter
AssigneeBoston Scientific Scimed, Inc.
InventorsBrendan Early Koop, Kara Elizabeth Garrott, Megan Wurden
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoston Scientific Scimed, Inc.
InventorsBrendan Early Koop, Kara Elizabeth Garrott, Megan Wurden
Estimating the term…
A system for ablating cardiac tissue through irreversible electroporation is disclosed. The system includes an electroporation and mapping catheter, a graphical display, and a controller coupled to the graphical display and the catheter. The catheter includes an electrode assembly defining a distally located central hub portion and splines, each spline including a distal end portion extending from the central hub portion, and a proximal end portion attached to and constrained by an outer shaft. The electrode assembly includes electrodes having sensing electrodes located on each spline. The controller determines an impedance from a four-terminal configuration wherein a current is injected to a current carrying pair of electrodes and a voltage is measured across a sensing pair of electrodes comprising sensing electrodes. The controller generates a graphical representation of a model of the impedance of the spline on the graphical display.
A system for ablating cardiac tissue through irreversible electroporation, the system comprising:
A system for ablating cardiac tissue through irreversible electroporation, the system comprising:
A system for ablating cardiac tissue through irreversible electroporation, the system comprising:
Dependencies are inferred from the claim text.